SCHEMBL19629072

SCHEMBL19629072

O=C1OCN2CCC[C@@]12COCc1ccccc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TACR1 P25103 3/20 0.37
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 2/20 0.36
TSHR P16473 1/20 0.35
LTA4H P09960 1/20 0.35
SLC6A4 P31645 2/20 0.34
MMP2 P08253 1/20 0.33
MMP3 P08254 1/20 0.33
MMP9 P14780 1/20 0.33
CTSV O60911 1/20 0.33
CTSL P07711 1/20 0.33
CTSB P07858 1/20 0.33
CTSS P25774 1/20 0.33
CTSK P43235 1/20 0.33
CTSC P53634 1/20 0.33
CTSF Q9UBX1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26694431 0.76 GRIN1 (0.43) TACR1MEN1KMT2ALTA4HSLC6A4
SCHEMBL19628503 0.74 LMNA (0.36) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL19627471 0.74 LMNA (0.36) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL19627465 0.74 LMNA (0.36) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL25051753 0.72 TACR1 (0.35) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL15029188 0.72 MEN1 (0.34) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL19614475 0.72 TACR1 (0.35) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL3595534 0.69 TACR1 (0.37) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL20512123 0.67 TACR1 (0.40) TACR1MEN1KMT2ANPSR1LMNA
SCHEMBL790547 0.66 TACR1 (0.41) TACR1MEN1KMT2ANPSR1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3458458-B1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC (US) 2020-11-04 EP disclosed
WO-2017201283-A1 SPIRO-LACTAM NMDA RECEPTOR MODULATORS AND USES THEREOF APTINYX INC. (US) 2017-11-23 WO disclosed